ReviewFrontiers in oncology2020

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors.

Karam Khaddour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.